The R&D laboratories located in Sydney, employ state of the art technologies to identify, produce and characterize therapeutic protein candidates. When these potential drugs have been demonstrated to have suitable drug-like properties and genuine scope to provide patient benefit they are transferred to other parts of Teva’s R&D organization for further development and progression to the clinic. The key skillsets of the Biologics R&D scientists are:

  • Protein and antibody engineering
  • Cell biology and pharmacology
  • Therapeutic protein production, purification and characterization.

Utilizing these technologies and expertise, the group has a track record of advancing several protein therapeutics into clinical trials.

Learn more about the technologies employed by our R&D team from Adam Clarke, Senior Director, Lead Antibody Discovery

Selected publications related to our research can be accessed via the links below: